Description
Hepatitis C virus (HCV) infection is a major health problem worldwide, with currently over 150 million HCV-infected people on the five continents. Although there have been important advances in the diagnosis, prevention and therapy, the infection remains an important health problem in most countries.HCV infection is considered a systemic disease: Not only does it affect the liver, it can induce autoimmune, dermatological and renal disease. Moreover, soon after the discovery of HCV as the major cause of non-A non-B hepatitis, HCV infection was recognized as an important cause and consequence of chronic kidney disease. The publication at hand is an update on the most important topics concerning HCV infection, renal disease and problems with dialysis in the general population as well as in renal transplant patients. Also included is a chapter on the emerging problem of renal complications associated with HCV virus in patients with HIV infection.Containing contributions from a panel of internationally acclaimed experts, this publication is a timely update on HCV infection and the kidney.
Chapter
Hepatitis C: Epidemiology, Diagnosis, Natural History and Therapy
Epidemiology and Diagnosis of HCV Infection
Natural History of HCV Infection
Treatment of HCV Infection
Hepatitis C and Renal Disease: Epidemiology, Diagnosis, Pathogenesis and Therapy
Epidemiology of Chronic Kidney Disease in Patients with HCV Infection
Diagnosis of Glomerular Diseases Associated with HCV Infection
Pathogenesis of Glomerulonephritis Associated with HCV Infection
Treatment of Glomerular Lesions Associated with HCV Infection
Hepatitis C-Induced Renal Disease in Patients with AIDS: An Emergent Problem
Renal Disease in HIV-Infected Patients
Hepatitis C-Induced Renal Disease in HIV-Infected Patients
Hepatitis C in Hemodialysis: Epidemiology and Prevention of Hepatitis C Virus Transmission
HCV Epidemiology in HD: The 1990s
Routes of Nosocomial HCV Transmission: Lessons from Molecular Virology Papers
Optimal Strategy to Prevent Nosocomial HCV Transmission in HD
Will the HCV Disappear from HD Units?
Current Prevalence of HCV in HD Patients
Attitude when Facing Seroconversion in a Chronic HD Patient
Hepatitis C-Related Liver Disease in Dialysis Patients
HCV-Related Liver Disease in Dialysis: Biochemical and Clinical Manifestation
Natural History of HCV in Dialysis Population
HCV: Survival and Hemodialysis
HCV: Survival and Peritoneal Dialysis
HCV: Survival and Cardiovascular Disease
HCV: Survival and Quality of Life
Natural History of HCV: Dialysis versus Non-Uremic Controls
HCV Viral Load: Uremic versus Non-Uremic Controls
Histopathology of HCV-Related Liver Disease in Dialysis and Non-Uremic Controls
Kinetics of HCV Load during Hemodialysis
Treatment of Hepatitis C in Dialysis Patients
Natural History of HCV Infection
Treating HCV Infection in the General Population
Justification for Treatment of HCV Infection in Dialysis Patients
Results of Treatment of Chronic HCV Infection in Dialysis Patients: Literature Review
Treatment of Acute HCV Infection in Dialysis Patients
Recommendations for the Treatment of HCV Infection in Dialysis Patients
Selection and Management of Hepatitis C Virus- Infected Patients for the Kidney Transplant Waiting List
Screening and Evaluation of Kidney Transplant Candidates for Hepatitis C Virus Infection
Characteristics of Wait- Listed Kidney Transplant Candidates with HCV Infection
Establishing Liver Disease Severity
Management of HCV-Infected Patients on the Kidney Waiting List
Treatment of HCV in Kidney Transplant Candidates
Kidney Transplantation in the Patient with Hepatitis C Virus Infection
Influence of HCV Infection on Rejection, Infection and Neoplasia
Impact of HCV Infection on Patient and Graft Survival after Kidney Transplantation
Treatment of Hepatitis C Virus Infection after Kidney Transplantation
Immunosuppression in Hepatitis C Virus- Infected Patients after Kidney Transplantation
Patient and Graft Survival
Impact of Immunosuppression in HCV-Infected Kidney Transplant Recipients
Optimal Immunosuppressive Regimen in HCV-Infected Kidney Transplant Recipients
Impact of Extrahepatic Complications (Diabetes and Glomerulonephritis) Associated with Hepatitis C Virus Infection after Renal Transplantation
HCV Infection as Risk Factor for New-Onset Diabetes after Transplantation
HCV-Related Glomerulonephritis in Renal Allografts
Renal Transplantation from Donors with a Positive Serology for Hepatitis C
Transmission of HCV Infection through Kidney Transplantation
Experience with the Transplantation of Kidneys from HCVD+
Suggested Strategies to Decrease HCV Transmission when Transplanting Kidneys from HCVD+
Kidneys from HCVD+: Surplus Organs?